Dale L. Barnard

Protease inhibitors targeting coronavirus and filovirus entry

Yanchen Zhou, P. Vedantham, Kai Lü et al. · Antiviral Research · 2015 · 626 citations · Full text

Life Sciences, Infectious Diseases, Medicinal Chemistry +14

Broad-Spectrum<i>In Vitro</i>Activity and<i>In Vivo</i>Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family<i>Coronaviridae</i>

Barry R. O’Keefe, Barbara Giomarelli, Dale L. Barnard et al. · Journal of Virology · 2009 · 304 citations

Life Sciences, Infectious Diseases, Host-pathogen Interactions +15

Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

Yoshikazu Honda‐Okubo, Dale L. Barnard, Chun Hao Ong et al. · Journal of Virology · 2014 · 226 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Evaluation of Immunomodulators, Interferons and Known <i>in Vitro</i> SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

Dale L. Barnard, Craig W. Day, Kevin W. Bailey et al. · Antiviral chemistry & chemotherapy · 2006 · 210 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus

Dale L. Barnard, John H. Huffman, Janis L.B. Morris et al. · Antiviral Research · 1992 · 170 citations

Medicine, Medicinal Chemistry, Pharmacology +10